Luisa Fernanda Echeverría-King
Directeur/Membre du Conseil chez International Centre For Genetic Engineering & Biotechnology
Profil
Luisa Fernanda Echeverría-King has a current job as a Member-Governors Board at the International Centre For Genetic Engineering & Biotechnology.
Postes actifs de Luisa Fernanda Echeverría-King
| Sociétés | Poste | Début |
|---|---|---|
International Centre For Genetic Engineering & Biotechnology
 International Centre For Genetic Engineering & Biotechnology Miscellaneous Commercial ServicesCommercial Services The International Centre for Genetic Engineering and Biotechnology is a research organization based in Trieste, Italy. The Italian company offers resources, tools, and know-how to fight the SARS-CoV-2 virus that causes COVID-19 to its member states free of charge. Additionally, the private company promotes international cooperation in developing and applying peaceful uses of genetic engineering and biotechnology, particularly for developing countries. The company's objective is to be the world's leading intergovernmental organization for research, training, and technology transfer in the field of life sciences and biotechnology. The company was founded in 1983, and Lawrence Banks has been the CEO since 2019. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
International Centre For Genetic Engineering & Biotechnology
International Centre For Genetic Engineering & Biotechnology Miscellaneous Commercial ServicesCommercial Services The International Centre for Genetic Engineering and Biotechnology is a research organization based in Trieste, Italy. The Italian company offers resources, tools, and know-how to fight the SARS-CoV-2 virus that causes COVID-19 to its member states free of charge. Additionally, the private company promotes international cooperation in developing and applying peaceful uses of genetic engineering and biotechnology, particularly for developing countries. The company's objective is to be the world's leading intergovernmental organization for research, training, and technology transfer in the field of life sciences and biotechnology. The company was founded in 1983, and Lawrence Banks has been the CEO since 2019. | Commercial Services |
